Surgical Oncology
-
Beyond the Scalpel: Improving Lung Resection Outcomes with Enhanced Recovery After Surgery Protocols
Dr. Cezary T. Piwkowski says growing literature suggests that optimized preoperative preparation or “prehabilitation” is critical to improving early postoperative outcomes.
-
Study Finds Correlations Between Certain Factors, Rates of Nodal Upstaging
Dr. Stella Martinez recently shared the latest data and explored the challenges and opportunities in lung cancer surgery in Latin America.
-
Debaters Argue Merits of Surgery in Malignant Meso in Light of MARS2 Data
Surgeon Erin Gillaspie, MD, said surgery still has a role in the treatment of mesothelioma while medical oncologist Hedy Kindler, MD, said newer systemic therapies make surgery obsolete in this space.
-
Recurrence Remains a Risk Even for Patients Diagnosed via Screening
Drs. Sara Ghandehari and Weijia Chua discuss how to best monitor patients when guidelines and protocols vary and more research is needed.
-
ELCC Session Offers Surgical Perspective in Context of Neoadjuvant Immunotherapy
Presenter Dr. Alex Brunelli says neoadjuvant chemoimmunotherapy is a promising and well-tolerated treatment option in select patients with stage III NSCLC.
-
Radiation Oncologist Makes Case for Radiotherapy for Local Treatment of Select Patients
Can radiotherapy replace surgery in stage III NSCLC in the era of immunotherapy? During ELCC 23, Dr. Sara Ramella turned to the data to answer that question.
-
Guideline-Concordant Surgery, Adjuvant Therapy, and the Promise of Curative-Intent Lung Cancer Surgery: What Are We Up Against?
In a “tale of two trials,” Drs. Ogbeide and Osarogiagbon use insights from the ALCHEMIST trial population to try to understand outcomes disparities between North America and Japan.
-
Quality of Life After VATS and SABR for Early-stage Lung Cancer: The Lilac Study
SABR patients were stable during the 12 months while surgical patients reported clinically significant deterioration at 6 weeks.
-
Management of Recurrences after Stereotactic Ablative Radiotherapy for Operable Early-Stage Non-Small Cell Lung Cancer
Practical aspects of clinically managing operable SABR patients are important for the long-term care of this unique population.
-
Bronchoscopic Ablation: A Small Step for Heat Therapy, a Giant Leap for Lung Cancer
Surgery has long been the gold standard for diagnosis and management of early-stage operable lung cancer. For patients with inoperable disease or more extensive disease, however, alternative approaches are emerging. […]
View ILCN Archives
Provider Resources